Our medical workforce shortage in Aotearoa is at a crisis point, struggling with growing unmet health need and increasing acuity of patients presenting at emergency departments. In response, there have been calls from a small but vocal physician associates (PAs) group to invest in their regulation and training.
Full article available to subscribers
Our medical workforce shortage in Aotearoa is at a crisis point, struggling with growing unmet health need and increasing acuity of patients presenting at emergency departments.1,2 In response, there have been calls from a small but vocal physician associates (PAs) group to invest in their regulation and training. Such calls are a misguided attempt at plugging crucial health workforce gaps and are underpinned by the flawed logic that more unqualified doctors are better than not enough qualified doctors.
However, a recent New Zealand Medical Journal editorial implies some medical colleges and the Medical Council of New Zealand have “concerns that regulation can wait, risk can be ignored, and regulation is not essential at this time.”3 This is disingenuous at best. Far from opposing regulation and risk management, as evidence-based practitioners we simply have yet to be presented with a robust case that PAs are the solution to our medical workforce crisis. We are already seeing the consequences of this failed experiment play out overseas, with substantial costs—both financial and to human lives. As such, we believe this discussion warrants a balanced argument.
Regulating and training PAs under a condensed medical model is dangerous and will result in clinical judgement, patient safety and quality of care being compromised. In fact, over 87% of doctors surveyed by the British Medical Association (BMA) believe the way PAs worked in the National Health Service were a risk to patient safety.4 The rush to regulation in the United Kingdom should serve as a cautionary tale, as it has resulted in the deaths of several patients who were misdiagnosed by PAs and who, at the time of being treated, were unaware they were not being seen by a doctor.4,5 This is in addition to over 70 instances of “avoidable patient harms and near misses”; at least 22 occasions of illegally prescribing controlled medications; and the ordering of over 1,000 unauthorised hospital scans by PAs.6–8
Adding to the harm is the intentionally deceptive use of “physician” in the PA title, violating the principle of informed consent for patients while posing clear risks to their safety.4 We have already had cases of medical error and patient confusion in Aotearoa, with a patient who nearly went blind after being misdiagnosed by a PA.9 In the long term this confusion—and resultant patient harm—will deteriorate public trust and confidence in our health system.
The medical profession has well-established, robust accountability frameworks—both professional and legislative. However, accountability does not lie solely in regulation. It lies in clinical competence and the responsibility for delivering an expected standard of safe care, grounded in the significant breadth and depth of training—and resultant clinical experience—that doctors have over PAs.
There is also the matter of whether it is appropriate for the regulatory body for medical practitioners to serve as the regulator for PAs, as this will further blur professional boundaries.4 Calls to have PAs as a regulated workforce in New Zealand miss the point because we are still left with risks to patient safety and issues around public confusion.
Next, we turn to the oft-lauded efficiencies gained from employing this lower-cost workforce. In fact, a quality trade-off has already been demonstrated with the use of PA workforces, and cost savings are largely clawed back through PAs practising more defensive medicine to compensate for limitations in medical diagnostic knowledge.10 There are also costs with regulating an entirely new workforce without an existing training programme. Given the current austerity climate and significant health funding shortfall, how will funds be prioritised toward establishing and monitoring rigorous education programmes, regulating the workforce and ensuring adequate resourcing for supervision and continuing professional development? And at whose expense? On balance, the growth and regulation of a PA workforce represents a false economy in the long term.
PAs have been touted as a “workforce multiplier”, allegedly (we are unable to find a source for this claim cited in the editorial), substituting up to 50–75% of a doctor’s work in a hospital setting—despite 55% of doctors in a BMA survey reporting their workload had increased with the employment of PAs.3,11 This claim also begs the question, which workforces need multiplying? Our healthcare issues stem from a lack of staff, not a lack of professions. As our population health needs become increasingly complex, we need more medical practitioners to meet this rising demand, rather than resorting to the cheapest skill mix. Further, a greater use of PA workforces—especially in rural areas—only serves to exacerbate existing inequities as entire population groups struggle to access appropriate medical care.
Lastly, there are opportunity costs of investing in regulation. Given the limits to PAs’ medical and diagnostic capabilities they will always need a level of oversight from qualified medical practitioners, who are already at or beyond capacity for supervising our own resident medical officers.12 Supervising PAs should not come at the expense of training our future doctors.
PAs also do not offer a unique or additive skillset beyond what a doctor, nurse or allied scientific and technical (AST) professional can do. If anything, the use of PAs to triage undifferentiated patients and hand over more complex and serious cases to doctors fragments the work of the medical profession. Continuously dealing with only the most complex and difficult cases strips doctors’ work of genuine connection and meaning, disrupts continuity of care, makes the process more prone to errors and contributes to burnout of this workforce.13
Those lauding the benefits of PAs primarily cite studies out of the United States, where expansion of this workforce has been fuelled by economic incentives of for-profit health providers.14 We must therefore be cautious about generalising these findings to Aotearoa and seriously probe whether this model of “care” is well suited to our local context, with its long-standing health inequities for tangata whenua.
Even the limited evidence of PA demonstrations in Aotearoa has been critiqued for its flawed methodology and resulting conclusions. It has also yet to definitively conclude that PAs are the best option for addressing our healthcare staffing crisis and meeting our population’s complex health needs.15
As evidence-based practitioners, we are alarmed at the speed with which we seem to be barrelling down the path of regulation, in the absence of any evidence of the economic or labour market value of PAs as a workforce in Aotearoa. If we continue down this path, we are doomed to repeat the same mistakes we’ve seen play out overseas.
Instead, we should be working to fix the root causes of our medical workforce recruitment and retention issues and supporting PAs to retrain as nurses or AST professionals or encouraging them into local medical school training to bring them up to the standard we expect. This is a clear win–win to bolster our health workforce through existing education pathways and registration, while maintaining faith in our medical professionals.
Natalia D’Souza: Research and Policy Advisor, New Zealand Resident Doctors’ Association, Auckland, Aotearoa New Zealand.
Dr Deborah Powell: National Secretary, New Zealand Resident Doctors’ Association, Auckland, Aotearoa New Zealand.
Sarah Dalton: Executive Director, Association of Salaried Medical Specialists – Toi Mata Hauora, Aotearoa New Zealand.
Natalia D’Souza: Research and Policy Advisor, New Zealand Resident Doctors’ Association, PO Box 11369, Ellerslie, Auckland 1542, Aotearoa New Zealand. Ph: 09 526 0280
Nil.
1) Keene L, Wild H, Mills V. Anatomy of a health crisis. N Z Med J. 2024 May 3;137(1594):9-12. doi: 10.26635/6965.6578.
2) Health New Zealand – Te Whatu Ora. Health Workforce Plan 2023/24 [Internet]. Wellington, New Zealand: Health New Zealand – Te Whatu Ora; 2023 [cited 2024 Jun 25]. Available from: https://www.tewhatuora.govt.nz/publications/health-workforce-plan-202324/
3) deWolfe L, Collins S. Regulation of physician associates in Aotearoa New Zealand mitigates a medical practitioner workforce crisis and leads to stronger, diversified healthcare teams. N Z Med J. 2024 Jul 19;137(1599):9-12. doi: 10.26635/6965.6616.
4) British Medical Association. BMA Briefing - Regulation of physician and anaesthesia associates - The Anaesthesia Associates and Physician Associates Order 2024 [Internet]. 2024 [cited 2024 Aug 2]. Available from: https://www.bma.org.uk/media/ez3nle22/bma-briefing-aapao-house-of-lords.pdf
5) Pickles K, Stearn E. 'Cut-price doctors' must NEVER diagnose patients under tough new crackdown sparked by death of actress, 30, whose fatal blood was missed twice [Internet]. Daily Mail; 2024 Mar 8 [cited 2024 Jun 27]. Available from: https://www.dailymail.co.uk/health/article-13168123/Cut-price-doctors-NEVER-diagnose-patients-tough-new-crackdown-sparked-death-actress-30-fatal-blood-missed-twice.html
6) UK Parliament. Anaesthesia Associates and Physician Associates Order 2024, Vol 836 [Internet]. Hansard; 2024 [cited 2024 Jul 10]. Available from: https://hansard.parliament.uk/Lords/2024-02-26/debates/4ED09D68-187C-4325-B4F3-E9F23712FD0C/AnaesthesiaAssociatesAndPhysicianAssociatesOrder2024
7) The Telegraph. Physician associates ‘illegally’ prescribe opiates to hospital patients [Internet]. 2024 Feb 22 [cited 2024 Jun 25]. Available from: https://www.telegraph.co.uk/news/2024/02/22/it-blunder-physician-associates-illegally-prescribe-opiates/
8) Price O. 'Cut-price' physician associates illegally ordered more than 1,000 NHS hospital tests including X-rays and CT scans despite not having any formal medical training - as doctors slam 'direct threat to patient safety' [Internet]. Daily Mail; 2024 Feb 3 [cited 2024 Jun 25]. Available from: https://www.dailymail.co.uk/news/article-13038173/Cut-price-physician-associates-illegally-ordered-1-000-NHS-hospital-tests-including-X-rays-CT-scans-despite-not-having-formal-medical-training-doctors-slam-direct-threat-patient-safety.html
9) Hill R. ‘He could have gone blind’: Concerns unregulated physician associates may put patients at risk [Internet]. Radio New Zealand; 2024 Jan 18 [cited 2024 Jun 25]. Available from: https://www.rnz.co.nz/news/national/506989/he-could-have-gone-blind-concerns-unregulated-physician-associates-may-put-patients-at-risk
10) Walia B, Banga H, Larsen DA. Increased reliance on physician assistants: an access-quality tradeoff? J Mark Access Health Policy. 2022 Jan 24;10(1):2030559. doi: 10.1080/20016689.2022.2030559.
11) Wise J. Physician associates increase doctors’ workloads, survey finds. BMJ. 2024 Feb 2;384:q291. doi: 10.1136/bmj.q291.
12) Andrew A. Aotearoa New Zealand general practice workforce crisis: what are our solutions? J Prim Health Care. 2024 Jun;16(2):214-217. doi: 10.1071/HC23178.
13) Zigmond D. The expansion of physician associates in primary care risks alienating an already ailing GP workforce. BMJ. 2024 Feb 15;384:q325. doi: 10.1136/bmj.q325.
14) Ferreira T. The role of the physician associate in the United Kingdom. Future Healthc J. 2024 Apr 20;11(2):100132. doi: 10.1016/j.fhj.2024.100132.
15) New Zealand Nurses Organisation. Critical Review of the final Evaluation of the HWNZ Physician Assistant Demonstration Pilot, Counties Manukau DHB [Internet]. 2012 [cited 2024 Jul 24]. Available from: https://www.nzno.org.nz/Portals/0/publications/Critical%20review%20of%20final%20Evaluation%20of%20the%20Physician%20Assistant%20pilot%202012.pdf
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz